Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Marcel Kool

Principal Investigator
Marcel Kool
Marcel Kool
Phone 088 97 29 000


  • SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors with Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome

    • sep. 2022
    • Martin, Hasselblatt, et al
    • American Journal of Surgical Pathology
  • Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors

    • sep. 2022
    • Lena, Blümel, et al
    • Cell Death and Disease
  • Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosis

    • aug. 2022
    • Laura E., Schultz-Rogers, et al
    • Developmental Dynamics
  • Target Actionability Review

    • feb. 2022
    • Kaylee M., Keller, et al
    • European Journal of Cancer
  • Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial

    • jan. 2022
    • B. Ole, Juhnke, et al
    • Neuro-Oncology
View all publications